WP
OKYO

Woodline Partners’s OKYO Pharma OKYO Stock Holding History

Woodline Partners’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.48M Buy
3,652,768
+578
+0% +$926 0.02% 677
2026
Q1 		$5.88M Buy
+3,652,190
New +$7.09M 0.02% 633

Other funds holding OKYO

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Woodline Partners's OKYO Position: Q2 2026 in Review

Woodline Partners increased its OKYO Pharma (OKYO) stake by 0.02% in Q2 2026, buying an estimated $926 and bringing the position to 3,652,768 shares worth $5.48M. The position accounts for 0.02% of the portfolio, ranked #677.

Woodline Partners first reported a position in OKYO in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.88M in Q1 2026. 19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

  • Woodline Partners held 3,652,768 shares of OKYO Pharma worth $5.48M as of Q2 2026.
  • Woodline Partners bought 578 OKYO Pharma shares in Q2 2026, an estimated $926.
  • OKYO Pharma made up 0.02% of Woodline Partners's portfolio in Q2 2026, its #677 holding.
  • Woodline Partners first reported a position in OKYO Pharma in Q1 2026 and has held it in 2 quarters since.
  • Woodline Partners's OKYO Pharma position peaked at $5.88M in Q1 2026.
  • 19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.